![](https://investorshub.advfn.com/uicon/496411.png?cb=1505403973)
Sunday, July 21, 2024 7:27:17 AM
Why not? BIEL's survey studies -- the evidence that you claim qualifies RecoveryRx for the NOPAIN Act -- were published in 2015 and 2019.
The CMS has approved one device, the ON-Q Pump, for reimbursement under the NOPAIN Act. Their clinical study was published in 2015. How did that device get approved?
Phrased a different way: why did the ON-Q Pump get approved while RecoveryRx did not?
Here is a clue: the clinical study for the ON-Q Pump that demonstrates a reduction in opioid use. How is this journal article different from BIEL's survey study journal articles?
https://pubmed.ncbi.nlm.nih.gov/26165259/
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM